Salihoglu Y - Search Results

1

Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.

Topuz E, Salihoglu Y, Aydiner A, Saip P, Tas F, Sozen T, Berkman S, Bengisu E. Topuz E, et al. Among authors: salihoglu y. J Surg Oncol. 2000 Jul;74(3):223-6. doi: 10.1002/1096-9098(200007)74:3<223::aid-jso14>3.0.co;2-q. J Surg Oncol. 2000. PMID: 10951423 Clinical Trial.

2

Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer.

Topuz E, Saip P, Aydmer A, Salihoğlu Y, Berkman S, Bengisu E. Topuz E, et al. Among authors: salihoglu y. Eur J Gynaecol Oncol. 1998;19(3):265-70. Eur J Gynaecol Oncol. 1998. PMID: 9641228 Clinical Trial.

3

Catheter complications associated with intraperitoneal chemotherapy.

Topuz E, Saip P, Aydiner A, Salihoglu Y, Aydin Y, Topuzlu C. Topuz E, et al. Among authors: salihoglu y. Eur J Gynaecol Oncol. 1998;19(3):275-9. Eur J Gynaecol Oncol. 1998. PMID: 9641230

4

Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.

Topuz E, Aydiner A, Saip P, Eralp Y, Taş F, Salihoğlu Y, Tenekeci N. Topuz E, et al. Among authors: salihoglu y. Eur J Gynaecol Oncol. 2000;21(6):599-602. Eur J Gynaecol Oncol. 2000. PMID: 11214619

5

The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma.

Topuz E, Eralp Y, Saip P, Aydiner A, Taş F, Saliho Y, Salihoğlu Y, Berkman S, Bengisu E. Topuz E, et al. Among authors: salihoglu y. Eur J Gynaecol Oncol. 2001;22(1):70-3. Eur J Gynaecol Oncol. 2001. PMID: 11321501

6

Thymidine labeling index in epithelial ovarian cancer.

Salihoglu Y, Bilir A, Aydiner A, Erkan M, Tuzlali S, Eralp Y. Salihoglu Y, et al. Int J Gynaecol Obstet. 2001 Nov;75(2):171-6. doi: 10.1016/s0020-7292(01)00455-6. Int J Gynaecol Obstet. 2001. PMID: 11684112

7

Nongenital metastatic cancers of the ovary: a clinical analysis.

Akhan SE, Kilic G, Salihoglu Y, Bengisu E, Berkman S. Akhan SE, et al. Among authors: salihoglu y. Eur J Gynaecol Oncol. 2001;22(5):379-83. Eur J Gynaecol Oncol. 2001. PMID: 11766746

8

The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.

Topuz E, Eralp Y, Aydiner A, Saip P, Taş F, Yavuz E, Salihoğlu Y. Topuz E, et al. Among authors: salihoglu y. Eur J Gynaecol Oncol. 2001;22(6):469-72. Eur J Gynaecol Oncol. 2001. PMID: 11874086

9

Prognostic role of nm23 gene expression in patients with ovarian cancer.

Tas F, Tuzlali S, Aydiner A, Saip P, Salihoglu Y, Iplikci A, Topuz E. Tas F, et al. Among authors: salihoglu y. Am J Clin Oncol. 2002 Apr;25(2):164-7. doi: 10.1097/00000421-200204000-00012. Am J Clin Oncol. 2002. PMID: 11943895

10

Brain metastasis of ovarian cancer after negative second-look laparotomy.

Akhan SE, Işikoglu M, Salihoglu Y, Bengisu E, Berkman S. Akhan SE, et al. Among authors: salihoglu y. Eur J Gynaecol Oncol. 2002;23(4):330-2. Eur J Gynaecol Oncol. 2002. PMID: 12214736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters